{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:33:18Z","timestamp":1762432398119,"version":"3.37.3"},"reference-count":26,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cathet Cardio Intervent"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>The Tack Endovascular System is a minimal\u2010metal dissection repair device that is purpose\u2010built to treat post\u2010percutaneous angioplasty (PTA) arterial dissections in patients with peripheral arterial disease (PAD). The Tack Optimized Balloon Angioplasty (TOBA) III trial evaluated the safety and effectiveness of the Tack Endovascular System in patients with superficial femoral artery (SFA) and\/or proximal popliteal artery (PPA) dissection after PTA with a drug\u2010coated balloon (DCB). The objective of this study is to report the results in the standard\u2010 (SL) and long\u2010lesion (LL) cohorts through 24 months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>The TOBA III study was a prospective, multicenter, single\u2010arm study including patients suffering from Rutherford category 2\u20134 PAD. Outcomes were assessed according to pre\u2010specified lesion length in SL (\u2009\u2265\u200920\u2009mm and \u2264150\u2009mm) and LL (\u2009&gt;\u2009150\u2009mm and \u2264250\u2009mm) cohorts. Follow\u2010up was through 24 months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>TOBA III enrolled 201 patients, 169 patients in the SL cohort and 32 in the LL cohort. At 24 months, the Kaplan\u2013Meier estimates of freedom from major adverse events were 91.7% and 82.6% for the SL cohort and LL cohort, respectively. Kaplan\u2013Meier estimates of freedom from clinically driven\u2010target lesion revascularization (CD\u2010TLR) were 92.3% in the SL cohort and 82.6% in the LL cohort. At 24 months, 78.8% of SL patients and 69.2% of LL patients experienced an improvement of &gt;2 Rutherford categories (both cohorts <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). The baseline ankle\u2010brachial index improved from 0.68\u2009\u00b1\u20090.18 to 0.93\u2009\u00b1\u20090.16 in the SL (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and from 0.62\u2009\u00b1\u20090.23 to 0.87\u2009\u00b1\u20090.15 in the LL cohort (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) at 24 months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The 24\u2010month results of the TOBA III trial support the safety and effectiveness of the Tack Endovascular System in patients who required post\u2010PTA dissection repair in the SFA and PPA following DCB angioplasty for claudication and rest pain. In both the SL and LL cohorts, Tack placement was associated with sustained freedom from CD\u2010TLR through 24 months as well as sustained improvements in Rutherford categories, ankle\u2010brachial index, and quality of life.<\/jats:p><\/jats:sec>","DOI":"10.1002\/ccd.30800","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T08:28:11Z","timestamp":1691656091000},"page":"701-712","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Optimized drug\u2010coated balloon angioplasty of the superficial femoral and proximal popliteal arteries using the Tack Endovascular System: Tack Optimized Balloon Angioplasty (TOBA) III 24\u2010month results in standard and long lesions"],"prefix":"10.1002","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6493-3799","authenticated-orcid":false,"given":"Marianne","family":"Brodmann","sequence":"first","affiliation":[{"name":"Division of Angiology Medical University Graz Graz Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Wissgott","sequence":"additional","affiliation":[{"name":"Imland Klinik Rendsburg Rendsburg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Brechtel","sequence":"additional","affiliation":[{"name":"Interventional Radiology Franziskus\u2010Hospital Berlin Berlin Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Lichtenberg","sequence":"additional","affiliation":[{"name":"Vascular Center Arnsberg Arnsberg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erwin","family":"Blessing","sequence":"additional","affiliation":[{"name":"SRH Klinikum Karlsbad\u2010Langensteinbach Karlsbad Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8476-0837","authenticated-orcid":false,"given":"Trisha","family":"Tarra","sequence":"additional","affiliation":[{"name":"Philips North America, LLC Cambridge Massachusetts USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Zeller","sequence":"additional","affiliation":[{"name":"Universitaets\u2010Herzzentrum Freiburg \u2013 Bad Krozingen Bad Krozingen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,8,10]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1067\/mva.2001.112210"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/0003319713488640"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004519"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2017.02.040"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.11.007"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2005.03.007"},{"issue":"8","key":"e_1_2_9_8_1","article-title":"Drug\u2010eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs","author":"Kayssi A","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X07079823"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.86.6.1845"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1177\/1526602817698634"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2017.08.092"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1583\/13-4392R.1"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2021.07.056"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.109.903468"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1583\/08-2676.1"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.689141"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2014.07.032"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/17434440.2021.1947243"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2019.08.005"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2020.01.078"},{"key":"e_1_2_9_22_1","first-page":"6","volume-title":"Coronary Artery Changes After PTCA: Manual of Operations, NHLBI PTCA Registry","author":"National, Heart, Lung, and Blood Institute","year":"1985"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.09.063"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2018.02.019"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2016.02.043"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051303"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.2147\/vhrm.1.1.73.58932"}],"container-title":["Catheterization and Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccd.30800","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T19:35:29Z","timestamp":1696534529000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ccd.30800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,10]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1002\/ccd.30800"],"URL":"https:\/\/doi.org\/10.1002\/ccd.30800","archive":["Portico"],"relation":{},"ISSN":["1522-1946","1522-726X"],"issn-type":[{"type":"print","value":"1522-1946"},{"type":"electronic","value":"1522-726X"}],"subject":[],"published":{"date-parts":[[2023,8,10]]},"assertion":[{"value":"2023-02-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}